Report from Europe: Rivals in DES sector report implants in Germany, Italy Feb. 22, 2008 By John Brosky
NewCo News: With Fresh Eggs, Stemagen Inc. Manages Fresh Cloning Start Feb. 22, 2008 By Anette Breindl
Genmab Pays $240M for PDL's Antibody Manufacturing Facility Feb. 22, 2008 By Jennifer Boggs Strengthening its position as a major antibody player, Genmab A/S said it is securing its own manufacturing capability in a deal to acquire troubled PDL BioPharma Inc.'s Brooklyn, Minn., facility for $240 million. (BioWorld Today)Read More
RSS